Sandbox:patho: Difference between revisions

Jump to navigation Jump to search
Newer edit →
VisualWikitext
Haytham Allaham (talk | contribs)
nocaptcha, Administrators
5,080 edits
Created page with "It is a neuroendocrine tumor, arising from any neural crest element of the sympathetic nervous system (SNS). It most frequently originates in one of the adrenal glands, but ca..."
 
Haytham Allaham (talk | contribs)
nocaptcha, Administrators
5,080 edits
No edit summary
Line 1: Line 1:
It is a neuroendocrine tumor, arising from any neural crest element of the sympathetic nervous system (SNS). It most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis.
* Neuroblastoma may be grouped according to the microscopic background stroma into a:
:* Schwannian stroma rich group
:* Schwannian stroma poor group


Neuroblastoma is one of the few human malignancies known to demonstrate spontaneous regression from an undifferentiated state to a completely benign cellular appearance
The most common location for neuroblastoma to originate (i.e., the primary tumor) is on the adrenal glands. This occurs in 40% of localized tumors and in 60% of cases of widespread disease. Neuroblastoma can also develop anywhere along the sympathetic nervous system chain from the neck to the pelvis. Frequencies in different locations include: neck (1%), chest (19%), abdomen (30% non-adrenal), or pelvis (1%). In rare cases, no primary tumor can be discerned.[10bout 1–2% of cases run in families and have been linked to specific gene mutations. Familial neuroblastoma in some cases is caused by rare germline mutations in the anaplastic lymphoma kinase (ALK) gene.[13] Germline mutations in the PHOX2A or KIF1B gene have been implicated in familial neuroblastoma as well. Neuroblastoma is also a feature of neurofibromatosis type 1 and the Beckwith-Wiedemann syndrome.


MYCN oncogene amplification within the tumor is a common finding in neuroblastoma. The degree of amplification shows a bimodal distribution: either 3- to 10-fold, or 100- to 300-fold. The presence of this mutation is highly correlated to advanced stages of disease.[14]
{{Family tree/start}}
Duplicated segments of the LMO1 gene within neuroblastoma tumor cells have been shown to increase the risk of developing an aggressive form of the cancer.[15]Neuroblastoma has been linked to copy-number variation within the NBPF10 gene, which results in the 1q21.1 deletion syndrome or 1q21.1 duplication syndrome.[16]
{{familytree  | | | | Y01 | | | | | | | | | | Y01=<div style="width: 20em; padding:0.5em;">'''Neuroblastoma'''</div>}}
{{familytree  | | |,|-|^|-|.| | | | | | | | }}
{{familytree  | | X01 | |  X02 | | | | | | |X01='''Schwannian stroma rich group'''| X02='''Schwannian stroma poor group'''}}
{{familytree|boxstyle= border-top: 0px;| | A01 | |  A03 | | | | | | |A01=<div style="width: 20em; padding:1em;">
'''Craniospinal radiation <u>OR</u> concurrent chemoradiotherapy followed by [[#Chemotherapy|chemotherapeutic regimens]]'''</div>|A03=<div style="width: 20em; padding:1em;">|A03=<div style="width: 20em; padding:1em;">
'''[[#Radiation Therapy|Craniospinal radiation]] followed by chemotherapeutic regimens'''</div>}}
{{Family tree/end}}

Revision as of 00:08, 6 October 2015

  • Neuroblastoma may be grouped according to the microscopic background stroma into a:
  • Schwannian stroma rich group
  • Schwannian stroma poor group


 
 
 
Neuroblastoma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schwannian stroma rich group
 
Schwannian stroma poor group
 
 
 
 
 
 
 
Craniospinal radiation OR concurrent chemoradiotherapy followed by chemotherapeutic regimens
 
Craniospinal radiation followed by chemotherapeutic regimens
 
 
 
 
 
 
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:patho&oldid=1169586"